0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > P-Selectin

P-Selectin

Brief Information

Name:P-selectin
Target Synonym:PADGEM,GRMP,Selectin P (Granule Membrane Protein 140kD, Antigen CD62),Platelet Alpha-Granule Membrane Protein,Granulocyte Membrane Protein,CD62P Antigen,Antigen CD62,P-Selectin,GMP140,CD62P,CD62,PSEL,Platelet Activation Dependent Granule-External Membrane
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
SEP-H5255 Human Human P-Selectin / CD62P Protein, Fc Tag
SEP-H5255-structure
SEP-H5255-sds
SEP-H52E4 Human Human P-Selectin / CD62P Protein, His Tag
SEP-H52E4-structure
SEP-H52E4-sds

Synonym Name

P-Selectin,CD62P,SELP,GMP-140

Background

P-selectin (SELP) is also known as CD62 antigen-like family member P, granule membrane protein 140 (GMP-140), leukocyte-endothelial cell adhesion molecule 3 (LECAM3) and platelet activation dependent granule-external membrane protein (PADGEM). SELP functions as a cell adhesion molecule (CAM) on the surfaces of activated endothelial cells, which line the inner surface of blood vessels, and activated platelets. In unactivated endothelial cells, it is stored in granules called Weibel-Palade bodies. In unactivated platelets SELP is stored in ¦Á-granules. The primary ligand for SELP is P-selectin glycoprotein ligand-1 (PSGL-1) which is expressed on almost all leukocytes, although P-selectin also binds to heparan sulfate and fucoidan. Furthermore, SELP has a functional role in metastasis of tumor similar to E-selectin, which can help cancer cells invade into bloodstream for metastasis and provided locally with multiple growth factors respectively.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Crizanlizumab Sel-G1; Sel-G-1; SEG-101 Approved Novartis Pharma Ag, Selexys Adakveo EU Anemia, Sickle Cell Novartis Europharm Ltd 2019-11-15 Primary Myelofibrosis; Priapism; Anemia, Sickle Cell Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Dociparstat sodium ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 Phase 3 Clinical Paringenix Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Leukemia, Myeloid, Acute; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Acute Lung Injury Details
Inclacumab RG-1512; RO-4905417; LC-1004-002; DSM-ACC-2641; R-1512 Phase 3 Clinical F. Hoffmann-La Roche Ltd, Genmab Myocardial Infarction; Peripheral Vascular Diseases; Pain; Acute Coronary Syndrome; Graft Occlusion, Vascular; Peripheral Arterial Disease; Anemia, Sickle Cell Details

This web search service is supported by Google Inc.

totop